CX 2023 Full programme
Nectero Sponsored Education - Tuesday, 25th April
Venue: Kensington 2 / Livestream 2
Time: 09:40 - 10:02
09:52 - 09:57
The Nectero clinical experience to date and future research/study plans - Tuesday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Medtronic Sponsored Education - Tuesday, 25th April
Venue: Admiral / Livestream 3
Time: 10:30 - 11:00
10:42 - 10:48
DCB Evidence through 3 Years: What it Means for My Algorithm - Tuesday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 1 Morning: Peripheral Arterial & Acute Limb Ischaemia & Randomised Control Trial Update - Tuesday, 25th April
Venue: Kensington 1 / Livestream 1
Time: 08:00 - 13:00
Peripheral Arterial Consensus Update - Tuesday, 25th April
Time: 08:00 - 09:40
| Anchor: | Roger Greenhalgh, London, United Kingdom |
| Moderators: | Andrew Holden, Auckland, New Zealand |
| Dittmar Boeckler, Heidelberg, Germany |
BASIL-2 Podium First Presentation - Tuesday, 25th April
Time: 11:10 - 13:00
| Anchor: | Roger Greenhalgh, London, United Kingdom |
| Moderators: | Andrew Holden, Auckland, New Zealand |
| Dittmar Boeckler, Heidelberg, Germany |
11:40 - 13:00
Audience Participation & Roundtable Discussion - Tuesday, 25th April
| Moderator: | Andrew Holden, Auckland, New Zealand |
Day 2 Morning: Abdominal Aortic - Wednesday, 26th April
Venue: Kensington 1 / Livestream 1
Time: 08:00 - 13:00
08:30 - 08:40
Edited Case: AAA sac filling with a bioabsorbable polymer (First-in-Human studies) - Wednesday, 26th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
11:10 - 11:15
IBE endograft for iliac artery preservation - Wednesday, 26th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
11:50 - 11:55
Experience with intravascular lithotripsy and balloon expandable covered stents in severely calcified aorta-iliac occlusive disease - Wednesday, 26th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Juxtarenal Aortic Consensus Update - Wednesday, 26th April
Time: 12:10 - 12:30
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Gustavo Oderich, Houston, United States |
| Roberto Chiesa, Milan, Italy |
Day 3 Morning: Thoracic Aortic - Thursday, 27th April
Venue: Kensington 1 / Livestream 1
Time: 08:00 - 13:00
08:30 - 08:35
Aortic arch stent graft system endograft for Zone 1 disease of the aortic arch - Thursday, 27th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Thoracic Consensus Update - Thursday, 27th April
Time: 14:20 - 15:20
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Gustavo Oderich, Houston, United States |
| Tilo Koelbel, Hamburg, Germany |
Best of Aortic Abstracts - Thursday, 27th April
Time: 15:20 - 15:50
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Gustavo Oderich, Houston, United States |
| Tilo Koelbel, Hamburg, Germany |
Day 1 Morning: Vascular Access - Tuesday, 25th April
Venue: Admiral / Livestream 3
Time: 08:00 - 13:00
11:00 - 11:05
Podium First: IN.PACT AV Access trial - 3 year subanalysis data - Tuesday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 1 Afternoon: Peripheral Arterial & Chronic Limb Threatening Ischaemia (CLTI) - Tuesday, 25th April
Venue: Kensington 1 / Livestream 1
Time: 13:30 - 18:00
Bioresorbable Drug-Coated Stents - Tuesday, 25th April
Time: 14:40 - 15:20
| Anchor: | Roger Greenhalgh, London, United Kingdom |
| Moderators: | Andrew Holden, Auckland, New Zealand |
| Dittmar Boeckler, Heidelberg, Germany |
15:00 - 15:05
Update on the EFEMORAL trial: Bioresorbable sirolimus-coated vascular balloon-expandable scaffold for femoropopliteal disease - Tuesday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
16:10 - 16:15
5-year follow-up of subjects with aortoiliac occlusive disease treated with a balloon expandable endoprosthesis - Tuesday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Chronic Limb-Threatening Ischaemia & Hurting Leg Consensus Update - Tuesday, 25th April
Time: 16:50 - 18:00
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Gunnar Tepe, Rosenheim, Germany |
| Peter Schneider, San Francisco, United States |
Day 1 Afternoon: Renal Interventions - Tuesday, 25th April
Venue: Admiral / Livestream 3
Time: 13:30 - 18:00
14:10 - 14:15
PTA: An older technology, with newer outcomes and procedural recommendations for treatment of arteriovenous access dysfunction - Tuesday, 25th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 2 Afternoon: Juxtarenal Aortic - Wednesday, 26th April
Venue: Kensington 1 / Livestream 1
Time: 13:30 - 18:00
14:30 - 14:35
Edited Case: Managing the angulated infra-renal aortic neck - Wednesday, 26th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Juxtarenal Aortic Consensus Update Continued - Wednesday, 26th April
Time: 16:10 - 16:40
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Gustavo Oderich, Houston, United States |
| Roberto Chiesa, Milan, Italy |
Juxtarenal Aortic Consensus Update: Bridging Stents - Wednesday, 26th April
Time: 16:40 - 17:30
| Anchor: | Andrew Holden, Auckland, New Zealand |
| Moderators: | Gustavo Oderich, Houston, United States |
| Roberto Chiesa, Milan, Italy |
Day 2 Afternoon: Best of Aortic Abstracts - Wednesday, 26th April
Venue: Admiral / Livestream 3
Time: 13:30 - 18:00
14:10 - 14:15
Three-year outcomes of a single branch off-the-shelf endovascular therapy for treating aortic arch pathologies - Wednesday, 26th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
Day 3: Innovation Showcase - Thursday, 27th April
Venue: Admiral / Livestream 3
Time: 08:00 - 18:00
10:30 - 10:35
Early localised drug treatment to inhibit growth of small and mid-size aneurysms - Thursday, 27th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
10:50 - 10:55
Podium First: First-in-human experience with the Vesteck Suture-tight device eliminating migration - Thursday, 27th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
11:20 - 11:25
Primary and secondary renal cell carcinoma tumor embolization with the GPX embolic device - Thursday, 27th April
| Speaker: | Andrew Holden, Auckland, New Zealand |
13:30 - 13:35
First-in-Human experience with the eFemoral bioresorbable scaffold in femoro-popliteal disease - Thursday, 27th April
| Speaker: | Andrew Holden, Auckland, New Zealand |